Access to anti-retroviral drugs, male in Morocco

Morocco: Access to anti-retroviral drugs, male was 65.0% in 2024. ◆ Volatile

Latest (2024)
65.0%
Change on year
up 4.8%
World rank
83rd
of 141 countries
All-time high
65.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, male in Morocco, 2000–2024

02040602000201220242000: 0 %2001: 0 %2002: 0 %2003: 4 %2004: 6 %2005: 7 %2006: 8 %2007: 10 %2008: 12 %2009: 14 %2010: 16 %2011: 19 %2012: 23 %2013: 27 %2014: 30 %2015: 33 %2016: 37 %2017: 40 %2018: 42 %2019: 45 %2020: 47 %2021: 59 %2022: 60 %2023: 62 %2024: 65 %

Source: UNAIDS estimates. Measured in %.

Analysis

Morocco recorded 65.0% for access to anti-retroviral drugs, male in 2024. That is the highest value across all 25 years on record.

That represents a change of up 4.8% on the previous year and up 116.7% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Morocco peaked at 65.0% in 2024 and was at its lowest, 0.0%, in 2000.

Morocco ranks 83rd of 141 countries on this measure, in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, male in Morocco, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Morocco, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 4.0%
2004 6.0% +50.0%
2005 7.0% +16.7%
2006 8.0% +14.3%
2007 10.0% +25.0%
2008 12.0% +20.0%
2009 14.0% +16.7%
2010 16.0% +14.3%
2011 19.0% +18.8%
2012 23.0% +21.1%
2013 27.0% +17.4%
2014 30.0% +11.1%
2015 33.0% +10.0%
2016 37.0% +12.1%
2017 40.0% +8.1%
2018 42.0% +5.0%
2019 45.0% +7.1%
2020 47.0% +4.4%
2021 59.0% +25.5%
2022 60.0% +1.7%
2023 62.0% +3.3%
2024 65.0% +4.8%

Averages by decade

DecadeAverage LowestHighest Years
2000s 6.1% 0.0% 14.0% 10
2010s 31.2% 16.0% 45.0% 10
2020s 58.6% 47.0% 65.0% 5

Countries ranked near Morocco

  1. 80 Cuba 66.0% compare
  2. 80 Guyana 66.0% compare
  3. 80 Slovakia 66.0% compare
  4. 83 Iraq 65.0% compare
  5. 83 Oman 65.0% compare
  6. 83 Serbia 65.0% compare

See the full ranking of 160 places →

More gender data for Morocco

All data for Morocco →

Frequently asked questions

What is access to anti-retroviral drugs, male in Morocco?
Access to anti-retroviral drugs, male in Morocco was 65.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Morocco?
The highest recorded value was 65.0% in 2024.
What is the lowest access to anti-retroviral drugs, male recorded in Morocco?
The lowest recorded value was 0.0% in 2000.
How does Morocco rank for access to anti-retroviral drugs, male?
Morocco ranks 83rd out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, male rising or falling in Morocco?
Over the last ten years it is up 116.7%. The long-run trend across the full record is volatile.
Where does this Morocco data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Morocco. Statizoid, drawing on UNAIDS estimates. Retrieved 07 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/morocco/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/morocco/">Access to anti-retroviral drugs, male in Morocco</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.